Skip to content

INDP - Indaptus Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Indaptus Therapeutics Inc

INDP · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

INDPIndaptus Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $7.45
52-wk low: $0.92
Prev close: $4.14
Mkt cap: $125.2M
Beta: 1.18
P/B: 11.0x

Smart money

3 funds hold a position.

Real smart money

Funds holding this stock

3 holders

Combined position$106K

CI
Citadel
Ken Griffin · Q1 2026 13F
$71K
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $125M

Valuation

P/B10.97

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: INDP
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $125.25M
Beta: 1.18

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-318.0%

$35K

position

BO

Bank of America

Q4 2025 13F

$73

position

Coverage gaps for INDP

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

-318.0%

ROA-98.1%

Growth

Beta1.18